drug reps to give out information about unapproved uses of their prescription drugs

The FDA will allow drug reps to give out information about UNAPPROVED uses of their prescription drugs.

Until now, drug reps could only give info about FDA-approved indications...even if their drug is commonly used "off-label."

That's why you've never seen a rep hand out info about verapamil for migraines...Neurontin for neuropathic pain...Wellbutrin for attention deficit disorder, etc.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote